title: Clinical leishmaniasis in dogs living in the UK.
abstract: OBJECTIVE
  To investigate the prevalence of leishmaniasis in dogs in the UK and to describe clinical presentation, clinicopathological abnormalities, therapeutic protocols and outcome in this non-endemic country.
  
  
  METHODS
  Medical records of dogs diagnosed with leishmaniasis at seven referral centres in the UK were retrospectively reviewed.
  
  
  RESULTS
  The prevalence was between 0·007 and 0·04% with a higher number of cases in southern England. All dogs had a history of travel to or from an endemic country. Lethargy, dermatological disease, decreased appetite and lameness were the most common reasons for presentation. Allopurinol was used alone for treatment in the majority of cases.
  
  
  CONCLUSIONS
  Although rare, leishmaniasis should be considered in dogs in the UK if they have compatible clinical signs and history of travel to or from endemic areas.
authors.affiliation: Department of Small Animal Internal Medicine, School of Veterinary Science, University of Liverpool, Neston CH64 7TE.
authors.forename: P
authors.initials: P
authors.lastname: Silvestrini
authors.affiliation: Department of Small Animal Internal Medicine, School of Veterinary Science, University of Liverpool, Neston CH64 7TE.
authors.forename: D
authors.initials: D
authors.lastname: Batchelor
authors.affiliation: Department of Veterinary Clinical Services, Royal Veterinary College of London, North Mymms, Herts NW1 0TU.
authors.forename: K
authors.initials: K
authors.lastname: Allenspach
authors.affiliation: Department of Small Animal Medicine, University of Bristol, Bristol, North Somerset BS40 5DU.
authors.forename: C
authors.initials: C
authors.lastname: Maunder
authors.affiliation: Department of Small Animal Internal Medicine, Animal Health Trust, Newmarket, Suffolk CB8 7UU.
authors.forename: M
authors.initials: M
authors.lastname: Seth
authors.affiliation: Anderson Moores Veterinary Specialists Ltd, Winchester SO212LL.
authors.forename: A
authors.initials: A
authors.lastname: Mas
authors.affiliation: Hospital for Small Animals, Royal (Dick) School of Veterinary Studies, University of Edinburgh, Edinburgh EH25 9RG.
authors.forename: T
authors.initials: T
authors.lastname: Hill
authors.affiliation: Department of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES.
authors.forename: G
authors.initials: G
authors.lastname: Serrano
authors.affiliation: Hospital Clinic Veterinari, Universitat Autonoma de Barcelona, 08193 Barcelona, Spain.
authors.forename: X
authors.initials: X
authors.lastname: Roura
authors.affiliation: Hospital Clinic Veterinari, Universitat Autonoma de Barcelona, 08193 Barcelona, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Planellas
authors.affiliation: Department of Small Animal Internal Medicine, School of Veterinary Science, University of Liverpool, Neston CH64 7TE.
authors.forename: A J
authors.initials: AJ
authors.lastname: German
authors.affiliation: Hospital Clinic Veterinari, Universitat Autonoma de Barcelona, 08193 Barcelona, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Pastor
mesh_terms: D000493:Allopurinol / Q000627:therapeutic use; D000818:Animals; D004196:Disease Outbreaks / Q000662:veterinary*; D004197:Disease Reservoirs / Q000662:veterinary; D004283:Dog Diseases / Q000188:drug therapy / Q000453:epidemiology* / Q000469:parasitology; D004285:Dogs; D004739:England / Q000453:epidemiology; D005260:Female; D007896:Leishmaniasis / Q000453:epidemiology / Q000662:veterinary*; D008297:Male; D008499:Medical Records; D015047:Zoonoses / Q000517:prevention & control
chemical_list: D000493:Allopurinol